Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
ZXDC	79364	broad.mit.edu	37	3	126189759	126189759	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr3:126189759G>A	ENST00000389709.3	-	4	1302	c.1249C>T	c.(1249-1251)Ccg>Tcg	p.P417S	ZXDC_ENST00000336332.5_Missense_Mutation_p.P417S	NM_025112.4	NP_079388.3	Q2QGD7	ZXDC_HUMAN	ZXD family zinc finger C	417		NA		NA	positive regulation of transcription, DNA-dependent	nucleus	C2H2 zinc finger domain binding|identical protein binding|LRR domain binding|nucleic acid binding|sequence-specific DNA binding transcription factor activity|zinc ion binding			endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(2)|lung(9)|ovary(1)	17				GBM - Glioblastoma multiforme(114;0.155)		CACTCGAACGGCTTTGTGCCT	0.463		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	115	123	120	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	126189759	NA	2198	4300	6498	SO:0001583	missense			ENSG00000070476	HGNC:28160	NM_025112	Approved	uc003eiv.3	NA	Q7L3L1|Q8NAU2	ENST00000389709.3	37	CCDS43145.1	.	.	.	.	.	.	.	.	.	.	G	18.53	3.643899	0.67244	.	.	ENSG00000070476	ENST00000389709;ENST00000336332	T;T	0.55930	0.49;0.49	4.61	4.61	0.57282	Zinc finger, C2H2 (1);Zinc finger, C2H2-type/integrase, DNA-binding (1);	0.000000	0.85682	D	0.000000	T	0.65386	0.2686	L	0.45228	1.405	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.91635	0.999;0.996	T	0.68957	-0.5272	10	0.87932	D	0	-16.4777	15.2783	0.73760	0.0:0.0:1.0:0.0	.	417;417	Q2QGD7-2;Q2QGD7	.;ZXDC_HUMAN	S	417	ENSP00000374359:P417S;ENSP00000337694:P417S	ENSP00000337694:P417S	P	-	1	0	ZXDC	127672449	1.000000	0.71417	0.990000	0.47175	0.358000	0.29455	9.848000	0.99507	2.268000	0.75426	0.484000	0.47621	CCG	ZXDC-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000370327.2	83.114493	KEEP		-	88.915582	0.270492	33	89	---	---	---	---	1	0.9019146	2	10	0	131	44	106	0	131	2	0	0	0	0	0	131	44	106	0	131	2	TP
SENP5	205564	broad.mit.edu	37	3	196612456	196612456	+	Missense_Mutation	SNP	A	A	G			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr3:196612456A>G	ENST00000323460.5	+	2	653	c.404A>G	c.(403-405)aAt>aGt	p.N135S	SENP5_ENST00000445299.2_Missense_Mutation_p.N135S|SENP5_ENST00000419026.1_Intron	NM_152699.4	NP_689912.2	Q96HI0	SENP5_HUMAN	SUMO1/sentrin specific peptidase 5	135		NA		NA	cell cycle|cell division|proteolysis	nucleolus	cysteine-type peptidase activity			NS(1)|breast(2)|endometrium(2)|kidney(3)|large_intestine(9)|lung(14)|skin(1)	32	all_cancers(143;1.8e-08)|Ovarian(172;0.0634)|Breast(254;0.135)		Epithelial(36;3.14e-24)|all cancers(36;2.1e-22)|OV - Ovarian serous cystadenocarcinoma(49;1.03e-18)|LUSC - Lung squamous cell carcinoma(58;1.51e-06)|Lung(62;1.95e-06)	GBM - Glioblastoma multiforme(46;0.004)		AGAGAGAAAAATCTCTTGAAG	0.443		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ovarian(47;891 1095 11174 13858 51271)					NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	51	51	51	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	196612456	NA	2203	4300	6503	SO:0001583	missense			ENSG00000119231	HGNC:28407	NM_152699	Approved	uc003fwz.4	NA	Q96SA5	ENST00000323460.5	37	CCDS3322.1	.	.	.	.	.	.	.	.	.	.	A	0.021	-1.421382	0.01126	.	.	ENSG00000119231	ENST00000323460;ENST00000445299	T;T	0.20598	2.37;2.06	5.03	0.167	0.15006	.	0.562739	0.18465	N	0.140404	T	0.05502	0.0145	N	0.01874	-0.695	0.80722	D	1	B;B	0.02656	0.0;0.0	B;B	0.04013	0.001;0.0	T	0.42949	-0.9421	10	0.02654	T	1	-2.2224	7.8168	0.29265	0.5783:0.0:0.4217:0.0	.	135;135	B4DY82;Q96HI0	.;SENP5_HUMAN	S	135	ENSP00000327197:N135S;ENSP00000390231:N135S	ENSP00000327197:N135S	N	+	2	0	SENP5	198096853	0.746000	0.28272	0.954000	0.39281	0.857000	0.48899	1.021000	0.30040	0.085000	0.17107	-0.242000	0.12053	AAT	SENP5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000340524.1	69.044643	KEEP		+	72.954952	0.265823	21	58	---	---	---	---	1	0.8180748	4	6	0	92	25	63	0	92	2	0	0	0	0	0	92	25	63	0	92	2	TP
C5orf22	55322	broad.mit.edu	37	5	31532447	31532447	+	5'UTR	SNP	C	C	T			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr5:31532447C>T	ENST00000355907.3	+	0	75				C5orf22_ENST00000325366.9_5'UTR|DROSHA_ENST00000513349.1_5'Flank|DROSHA_ENST00000504361.1_5'Flank|DROSHA_ENST00000511367.2_5'Flank			Q49AR2	CE022_HUMAN	chromosome 5 open reading frame 22	NA		NA		NA						kidney(3)|large_intestine(2)|lung(10)|ovary(2)|skin(1)	18						CCGGCTTTCCCGGGTCTTCTC	0.667		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11	14	13	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	31532447	NA	691	1590	2281	SO:0001623	5_prime_UTR_variant			ENSG00000082213	HGNC:25639	NM_018356	Approved	uc003jhj.4	NA	Q8ND28|Q8WU61|Q9NUR1	ENST00000355907.3	37																																																																																				C5orf22-201	KNOWN	basic	protein_coding	NA	protein_coding		14.899206	KEEP		+	18.885161	0.175	7	33	---	---	---	---	1	0.742785	2	13	0	45	7	35	0	45	2	0	0	0	0	0	45	7	35	0	45	2	TP
ZBTB22	0	broad.mit.edu	37	6	33282984	33282984	+	Silent	SNP	G	G	A			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr6:33282984G>A	ENST00000431845.2	-	2	1861	c.1710C>T	c.(1708-1710)ggC>ggT	p.G570G	TAPBP_ENST00000475304.1_5'Flank|TAPBP_ENST00000489157.1_5'Flank|ZBTB22_ENST00000418724.1_Silent_p.G570G|TAPBP_ENST00000426633.2_5'Flank|TAPBP_ENST00000456592.2_5'Flank|TAPBP_ENST00000434618.2_5'Flank	NM_005453.4	NP_005444.4	O15209	ZBT22_HUMAN	zinc finger and BTB domain containing 22	570		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|central_nervous_system(1)|endometrium(3)|large_intestine(1)|lung(9)|ovary(2)|prostate(1)|urinary_tract(3)	21						CCCCGACCCCGCCCAGGCGGT	0.687		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	25	28	27	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	33282984	NA	2198	4292	6490	SO:0001819	synonymous_variant			ENSG00000236104	HGNC:13085		Approved	uc010juu.3	NA	B0V007|Q5HYV4|Q5STL0|Q5STR7|Q8WV82	ENST00000431845.2	37	CCDS4775.1																																																																																			ZBTB22-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000076183.2	37.79203	KEEP		-	43.371888	0.225	18	62	---	---	---	---	1	0.9938687	6	25	0	76	20	66	0	76	2	0	0	0	0	0	76	20	66	0	76	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Colon(40;35 892 2973 5743 27438)		Dom	yes		7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	112	104	107	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	140453136	NA	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	69.540573	KEEP		-	73.536669	0.277778	25	65	---	---	---	---	1	0.913336	8	6	0	110	27	74	0	110	2	1	1	91	239	0	110	27	74	0	110	2	TP
LONRF1	91694	broad.mit.edu	37	8	12580704	12580704	+	Silent	SNP	T	T	C			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr8:12580704T>C	ENST00000398246.3	-	12	2292	c.2223A>G	c.(2221-2223)ccA>ccG	p.P741P	LONRF1_ENST00000533751.1_Silent_p.P384P|LONRF1_ENST00000525024.1_Silent_p.P167P	NM_152271.3	NP_689484.3	Q17RB8	LONF1_HUMAN	LON peptidase N-terminal domain and ring finger 1	741	Lon.	NA		NA	proteolysis		ATP-dependent peptidase activity|zinc ion binding			breast(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(5)|lung(4)|ovary(1)|upper_aerodigestive_tract(2)	19				READ - Rectum adenocarcinoma(644;0.236)		GCTGGTATCGTGGGTCTACAG	0.418		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	133	138	136	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	12580704	NA	1941	4125	6066	SO:0001819	synonymous_variant			ENSG00000154359	HGNC:26302	NM_152271	Approved	uc003wwd.1	NA	B4DM29|B4DU84|Q8TEA0|Q9BSV1	ENST00000398246.3	37	CCDS5987.2																																																																																			LONRF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251693.2	135.176621	KEEP		-	145.096228	0.254144	46	135	---	---	---	---	1	0.9982333	5	25	0	198	58	161	0	198	2	0	0	0	0	0	198	58	161	0	198	2	TP
ARNTL	406	broad.mit.edu	37	11	13393916	13393916	+	Silent	SNP	C	C	A			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr11:13393916C>A	ENST00000389708.3	+	13	1382	c.1027C>A	c.(1027-1029)Cgg>Agg	p.R343R	ARNTL_ENST00000396441.3_Silent_p.R342R|ARNTL_ENST00000403482.3_Silent_p.R341R|ARNTL_ENST00000403510.3_Silent_p.R299R|ARNTL_ENST00000497429.1_3'UTR|ARNTL_ENST00000389707.4_Silent_p.R342R|ARNTL_ENST00000361003.4_Intron|ARNTL_ENST00000403290.1_Silent_p.R343R|ARNTL_ENST00000401424.1_Silent_p.R300R			O00327	BMAL1_HUMAN	aryl hydrocarbon receptor nuclear translocator-like	343	PAS 2.	NA		NA	circadian rhythm|positive regulation of transcription from RNA polymerase II promoter	transcription factor complex	aryl hydrocarbon receptor binding|DNA binding|Hsp90 protein binding|sequence-specific DNA binding transcription factor activity|signal transducer activity			breast(1)|endometrium(2)|large_intestine(11)|lung(5)|upper_aerodigestive_tract(1)	20				Epithelial(150;0.0243)		ATATGTTTCTCGGCACGCGAT	0.443		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	138	124	128	NA	NA	NA	NA	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	13393916	NA	2200	4294	6494	SO:0001819	synonymous_variant			ENSG00000133794	HGNC:701	NM_001178	Approved	uc001mkp.3	NA	A8K645|B5ME11|B7WPG7|D3DQW6|O00313|O00314|O00315|O00316|O00317|Q4G136|Q8IUT4|Q99631|Q99649	ENST00000389708.3	37																																																																																				ARNTL-202	KNOWN	basic	protein_coding	NA	protein_coding		-18.434712	KEEP		+	7.443365	0.036036	4	107	---	---	---	---	1	0.9974335	2	248	0	143	6	121	0	143	2	0	0	0	0	0	143	6	121	0	143	2	TP
BRCA2	675	broad.mit.edu	37	13	32937551	32937551	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr13:32937551G>T	ENST00000544455.1	+	18	8439	c.8212G>T	c.(8212-8214)Gct>Tct	p.A2738S	BRCA2_ENST00000380152.3_Missense_Mutation_p.A2738S	NM_000059.3	NP_000050.2	P51587	BRCA2_HUMAN	breast cancer 2, early onset	2738		NA		NA	cell cycle cytokinesis|centrosome duplication|double-strand break repair via homologous recombination|negative regulation of mammary gland epithelial cell proliferation|nucleotide-excision repair|positive regulation of transcription, DNA-dependent|regulation of S phase of mitotic cell cycle	BRCA2-MAGE-D1 complex|centrosome|nucleoplasm|stored secretory granule	gamma-tubulin binding|H3 histone acetyltransferase activity|H4 histone acetyltransferase activity|protease binding|single-stranded DNA binding			NS(3)|breast(13)|central_nervous_system(5)|cervix(2)|endometrium(24)|haematopoietic_and_lymphoid_tissue(1)|kidney(10)|large_intestine(32)|liver(1)|lung(41)|oesophagus(5)|ovary(22)|pancreas(4)|prostate(3)|salivary_gland(1)|skin(11)|upper_aerodigestive_tract(2)|urinary_tract(3)	183		Lung SC(185;0.0262)		all cancers(112;7.13e-07)|Epithelial(112;1.59e-05)|OV - Ovarian serous cystadenocarcinoma(117;0.000732)|BRCA - Breast invasive adenocarcinoma(63;0.0291)|GBM - Glioblastoma multiforme(144;0.0704)		TCCCCTCTTAGCTGTCTTAAA	0.458		NA	"""D, Mis, N, F, S"""		"""breast, ovarian, pancreatic"""	"""breast, ovarian, pancreatic, leukemia  (FANCB, FANCD1)"""		Homologous recombination	Pancreatic Cancer, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Prostate Cancer;Hereditary Breast-Ovarian Cancer, BRCA2 type;Fanconi Anemia type D1, bi-allelic BRCA2 mutations;Fanconi Anemia	TCGA Ovarian(8;0.087)			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Esophageal Squamous(138;838 1285 7957 30353 30468 36915 49332)	yes	Rec	yes	Hereditary breast/ovarian cancer	13	13q12	675	familial breast/ovarian cancer gene 2		"""L, E"""	0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	129	123	125	NA	NA	NA	NA	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	32937551	NA	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl.: Hereditary Pancreatic Adenocarcinoma, Insulin-Dependent Diabetes Mellitus - Exocrine Insufficiency - Familial Pancreatic Cancer, PNCA1;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;HPC; ;FANCD1;Pancytopenia Dysmelia, FA (several complementation groups)	ENSG00000139618	HGNC:1101	NM_000059	Approved	uc001uub.1	NA	O00183|O15008|Q13879|Q5TBJ7	ENST00000544455.1	37	CCDS9344.1	.	.	.	.	.	.	.	.	.	.	G	14.34	2.505659	0.44558	.	.	ENSG00000139618	ENST00000380152;ENST00000544455	T;T	0.80214	-1.35;-1.35	5.49	4.64	0.57946	Nucleic acid-binding, OB-fold-like (1);BRCA2, oligonucleotide/oligosaccharide-binding 1 (1);	0.236160	0.42294	D	0.000723	T	0.77678	0.4166	L	0.48218	1.51	0.39658	D	0.970577	P	0.35821	0.523	B	0.43018	0.405	T	0.76233	-0.3034	10	0.38643	T	0.18	.	9.7781	0.40632	0.0727:0.0:0.7872:0.14	.	2738	P51587	BRCA2_HUMAN	S	2738	ENSP00000369497:A2738S;ENSP00000439902:A2738S	ENSP00000369497:A2738S	A	+	1	0	BRCA2	31835551	0.994000	0.37717	0.013000	0.15412	0.896000	0.52359	4.327000	0.59247	1.321000	0.45227	0.313000	0.20887	GCT	BRCA2-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		66.570307	KEEP		+	72.533472	0.252336	27	80	---	---	---	---	0	0	0	0	0	137	29	90	0	137	2	1	1	319	632	0	137	29	90	0	137	2	TP
NYNRIN	57523	broad.mit.edu	37	14	24877450	24877450	+	Silent	SNP	C	C	T			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr14:24877450C>T	ENST00000382554.3	+	3	892	c.574C>T	c.(574-576)Ctg>Ttg	p.L192L		NM_025081.2	NP_079357.2	Q9P2P1	NYNRI_HUMAN	NYN domain and retroviral integrase containing	192		NA		NA	DNA integration	integral to membrane	DNA binding			breast(3)|central_nervous_system(1)|endometrium(7)|kidney(6)|large_intestine(8)|lung(21)|ovary(2)|prostate(4)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	56						GCTGCTGAGCCTGGTGCGGGA	0.652		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	19	25	23	NA	NA	NA	NA	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	24877450	NA	2078	4207	6285	SO:0001819	synonymous_variant				HGNC:20165		Approved	uc001wpf.4	NA	Q6P153|Q86TR3|Q9HAC4	ENST00000382554.3	37	CCDS45090.1																																																																																			NYNRIN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000412939.1	17.041928	KEEP		+	17.906836	0.285714	6	15	---	---	---	---	1	0.679773	2	5	0	39	7	16	0	39	2	0	0	0	0	0	39	7	16	0	39	2	TP
MESDC2	23184	broad.mit.edu	37	15	81282072	81282072	+	Silent	SNP	G	G	A			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr15:81282072G>A	ENST00000261758.4	-	1	147	c.61C>T	c.(61-63)Ctg>Ttg	p.L21L	RP11-775C24.3_ENST00000563737.1_lincRNA	NM_015154.1	NP_055969.1	Q14696	MESD_HUMAN	mesoderm development candidate 2	21	Chaperone domain (By similarity).	NA		NA	mesoderm development|protein folding|Wnt receptor signaling pathway	endoplasmic reticulum				cervix(1)|large_intestine(5)|ovary(1)|urinary_tract(1)	8						agcagcagcagcagcagGTCA	0.682		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	25	24	24	NA	NA	NA	NA	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	81282072	NA	2201	4298	6499	SO:0001819	synonymous_variant				HGNC:13520	NM_015154	Approved	uc002bfy.1	NA	D3DW96|Q969U1	ENST00000261758.4	37	CCDS32308.1																																																																																			MESDC2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000417673.2	7.38508	KEEP		-	9.479248	0.181818	4	18	---	---	---	---	1	0.9957778	20	45	0	35	4	18	0	35	2	0	0	0	0	0	35	4	18	0	35	2	TP
PRKCSH	5589	broad.mit.edu	37	19	11559445	11559445	+	Splice_Site	SNP	G	G	T			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chr19:11559445G>T	ENST00000252455.2	+	14	1601		c.e14+1		PRKCSH_ENST00000592741.1_Splice_Site|PRKCSH_ENST00000587327.1_Splice_Site|PRKCSH_ENST00000589838.1_Splice_Site|PRKCSH_ENST00000412601.1_Splice_Site|PRKCSH_ENST00000591462.1_Splice_Site	NM_002743.2	NP_002734.2	P14314	GLU2B_HUMAN	protein kinase C substrate 80K-H	NA		NA		NA	innate immune response|intracellular protein kinase cascade|post-translational protein modification|protein folding|protein N-linked glycosylation via asparagine	endoplasmic reticulum lumen	calcium ion binding|protein kinase C binding			breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(2)|lung(7)|ovary(2)|pancreas(1)|prostate(3)	19						CCACCAACGAGTGCGTCCCAG	0.617		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	72	77	75	NA	NA	NA	NA	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11559445	NA	2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000130175	HGNC:9411		Approved	uc002mrt.3	NA	Q96BU9|Q96D06|Q9P0W9	ENST00000252455.2	37	CCDS32911.1	.	.	.	.	.	.	.	.	.	.	G	18.69	3.679084	0.68042	.	.	ENSG00000130175	ENST00000252455;ENST00000412601	.	.	.	4.78	4.78	0.61160	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.6404	0.85070	0.0:0.0:1.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	PRKCSH	11420445	1.000000	0.71417	0.953000	0.39169	0.598000	0.36846	8.326000	0.90010	2.217000	0.71921	0.456000	0.33151	.	PRKCSH-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		62.358063	KEEP	Intron	+	66.457373	0.272727	24	64	---	---	---	---	1	1	110	1	0	100	27	74	0	100	2	0	0	0	0	0	100	27	74	0	100	2	TP
USP9X	8239	broad.mit.edu	37	X	41075213	41075213	+	Missense_Mutation	SNP	A	A	C			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chrX:41075213A>C	ENST00000324545.7	+	35	6026	c.5393A>C	c.(5392-5394)aAg>aCg	p.K1798T	USP9X_ENST00000378308.2_Missense_Mutation_p.K1798T	NM_001039590.2|NM_001039591.2	NP_001034679.2|NP_001034680.2	Q93008	USP9X_HUMAN	ubiquitin specific peptidase 9, X-linked	1798		NA		NA	BMP signaling pathway|cell division|chromosome segregation|female gamete generation|mitosis|protein deubiquitination|transforming growth factor beta receptor signaling pathway|ubiquitin-dependent protein catabolic process	cytoplasm	co-SMAD binding|cysteine-type endopeptidase activity|ubiquitin thiolesterase activity			NS(3)|breast(6)|central_nervous_system(1)|endometrium(14)|haematopoietic_and_lymphoid_tissue(3)|kidney(6)|large_intestine(16)|lung(29)|ovary(2)|prostate(3)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	87						ATACAACTAAAGCGATTTGAC	0.363		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Ovarian(172;1807 2695 35459 49286)					NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	78	74	76	NA	NA	NA	NA	X	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	41075213	NA	2062	4242	6304	SO:0001583	missense			ENSG00000124486	HGNC:12632	NM_004652	Approved	uc004dfb.3	NA	O75550|Q8WWT3|Q8WX12	ENST00000324545.7	37	CCDS43930.1	.	.	.	.	.	.	.	.	.	.	A	20.8	4.054648	0.75960	.	.	ENSG00000124486	ENST00000378308;ENST00000324545	T;T	0.39229	1.09;1.09	5.67	5.67	0.87782	Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2 (2);	0.000000	0.85682	D	0.000000	T	0.75568	0.3867	H	0.96547	3.84	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.97110	0.999;1.0	D	0.84091	0.0390	10	0.87932	D	0	.	14.9351	0.70948	1.0:0.0:0.0:0.0	.	1798;1798	Q93008-1;Q93008	.;USP9X_HUMAN	T	1798	ENSP00000367558:K1798T;ENSP00000316357:K1798T	ENSP00000316357:K1798T	K	+	2	0	USP9X	40960157	1.000000	0.71417	1.000000	0.80357	0.981000	0.71138	8.906000	0.92626	1.909000	0.55274	0.486000	0.48141	AAG	USP9X-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000056250.3	109.38776	KEEP		+	111.971949	0.333333	35	70	---	---	---	---	1	0.9999998	30	25	0	86	39	74	0	86	2	0	0	0	0	0	86	39	74	0	86	2	TP
NGFRAP1	27018	broad.mit.edu	37	X	102632483	102632483	+	Missense_Mutation	SNP	C	C	T			THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A3H5-Tumor-SM-2HRLD	THCA-TCGA-EL-A3H5-Normal-SM-2HRLI	g.chrX:102632483C>T	ENST00000361298.4	+	3	399	c.34C>T	c.(34-36)Cgc>Tgc	p.R12C	NGFRAP1_ENST00000372634.1_Missense_Mutation_p.R12C|NGFRAP1_ENST00000372635.1_Missense_Mutation_p.R22C|NGFRAP1_ENST00000299872.7_Missense_Mutation_p.R22C|NGFRAP1_ENST00000372645.3_Missense_Mutation_p.R22C	NM_206915.1|NM_206917.1	NP_996798.1|NP_996800.1	Q00994	BEX3_HUMAN	nerve growth factor receptor (TNFRSF16) associated protein 1	22		NA		NA	apoptosis|multicellular organismal development|nerve growth factor receptor signaling pathway	cytosol|nucleus	caspase regulator activity|metal ion binding			NS(2)|endometrium(1)|large_intestine(2)|lung(4)|urinary_tract(1)	10						AGAGGAAGACCGCCCTTTGGG	0.498		NA											NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA				0			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	159	156	157	NA	NA	NA	NA	X	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	102632483	NA	2203	4300	6503	SO:0001583	missense			ENSG00000166681	HGNC:13388	NM_014380	Approved	uc004ekj.1	NA	B2RD17|D3DXA3|Q5JQT4|Q5JQT5	ENST00000361298.4	37	CCDS14509.1	.	.	.	.	.	.	.	.	.	.	C	13.56	2.272384	0.40194	.	.	ENSG00000166681	ENST00000361298;ENST00000372645;ENST00000372635;ENST00000372634;ENST00000299872	T;T;T;T;T	0.11385	2.78;2.78;2.78;2.78;2.78	3.68	3.68	0.42216	.	0.162424	0.29767	N	0.011260	T	0.04907	0.0132	N	0.11000	0.08	0.42515	D	0.992986	D	0.58970	0.984	B	0.37267	0.245	T	0.42865	-0.9426	10	0.46703	T	0.11	-0.3257	9.9539	0.41655	0.0:1.0:0.0:0.0	.	22	Q00994	BEX3_HUMAN	C	12;22;22;12;22	ENSP00000354843:R12C;ENSP00000361728:R22C;ENSP00000361718:R22C;ENSP00000361717:R12C;ENSP00000299872:R22C	ENSP00000299872:R22C	R	+	1	0	NGFRAP1	102519139	1.000000	0.71417	0.999000	0.59377	0.984000	0.73092	2.711000	0.47177	2.101000	0.63845	0.529000	0.55759	CGC	NGFRAP1-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000057710.1	150.901333	KEEP		+	175.887169	0.208202	66	251	---	---	---	---	1	1	176	274	0	412	76	288	0	412	2	0	0	0	0	0	412	76	288	0	412	2	TP
